19:46:49 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



T:TH - THERATECHNOLOGIES INC. - https://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  0.14.30·4.325.04.30-0.02-0.541.3175864.31  4.32  4.304.34  1.5915:59:30Jul 0915 min RT 2¢
TSX - T0.14.30·4.325.04.30-0.02-0.526.8114504.31  4.31  4.304.34  1.5915:59:3015 min
NEO ATS - U 4.30-0.02-0.51.0414.30  4.30  4.3015:59:3015 min
Omega - O 4.30-0.02-0.55.222134.30  4.32  4.3015:59:3015 min
Chi-X - X 4.31-0.01-0.23.91744.31  4.31  4.3115:54:2515 min
CX2 - H 4.30-0.02-0.51.1514.30  4.30  4.3015:59:3015 min
CXD - D 4.31-0.01-0.21.6784.31  4.31  4.3113:48:1615 min
TriAct - M 4.321.778    Sep 11-2015 min
CS2 - S 4.320.011    Jul 1015 min

Recent Trades - Last 10 of 86
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:50M4.32 7879 CIBC79 CIBCE
15:59:30H4.30-0.021,10079 CIBC79 CIBCK
15:59:30U4.30-0.021,00079 CIBC1 AnonymousK
15:59:30T4.30-0.0240079 CIBC1 AnonymousK
15:59:30O4.30-0.021,20079 CIBC1 AnonymousK
15:59:30O4.30-0.0220080 National Bank1 AnonymousK
15:59:29T4.31-0.0110039 Merrill Lynch1 AnonymousK
15:56:35M4.315-0.00510079 CIBC1 Anonymous
15:56:02T4.31-0.01507 TD Sec57 Interactive
15:54:25X4.31-0.0120080 National Bank1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-09 08:12C:TH4.30SEDAR Interim MD & ASEDAR Interim MD & A
2025-07-09 08:06C:TH4.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-07-09 07:30C:TH4.30News ReleaseTheratechnologies Reports Financial Results for the Second Quarter 2025
2025-07-03 20:13C:TH4.23News ReleaseTheratechnologies to release Q2 2025 results July 9
2025-07-02 22:11C:TH3.21News ReleaseTheratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
2025-05-29 19:20C:TH3.58News ReleaseTheratechnologies shareholders approve AGM resolutions
2025-05-02 07:30C:TH4.04News ReleaseTheratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
2025-04-15 19:37C:TH3.71News ReleaseTheratechnologies to continue non-exclusively for sale
2025-04-11 17:44C:TH2.70News ReleaseTheratechnologies, potential acquiror in talks for deal
2025-04-09 08:19C:TH2.21SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-04-09 08:19C:TH2.21SEDAR Interim MD & ASEDAR Interim MD & A
2025-04-09 07:30C:TH2.21News ReleaseTheratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
2025-04-08 16:37C:TH2.21News ReleaseTheratechnologies gets U.S. FDA OK for Egrifta SV PAS
2025-04-03 18:17C:TH2.11News ReleaseTheratechnologies to release Q1 2025 results April 9
2025-03-25 19:25C:TH2.21News ReleaseTheratechnologies receives FDA OK for Egrifta treatment
2025-03-12 14:33C:TH2.18News ReleaseTheratechnologies talks CV study in people with HIV
2025-03-12 14:14C:TH2.18News ReleaseTheratechnologies talks ibalizumab study on HIV RNA
2025-02-26 08:30C:TH2.59SEDAR Annual ReportSEDAR Annual Report
2025-02-26 08:19C:TH2.59SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-02-26 08:19C:TH2.59SEDAR MD & ASEDAR MD & A